Related by context. Frequent words. (Click for all words.) 72 randomized Phase 72 randomized Phase III 71 Pivotal Phase 71 Phase III randomized 71 phase IIb 70 phase IIa 70 dose escalation trial 70 Phase 2b study 70 Phase 2a clinical 69 Phase 1b 69 Phase IIa clinical 69 pivotal Phase 69 Phase IIa trial 68 Phase Ib 68 Phase 2a trial 68 phase 2a 68 Phase 1b clinical 67 Phase 2a 67 label multicenter 67 Phase 2b clinical 67 Phase 2b 67 multicenter randomized double 67 registrational 66 placebo controlled randomized 66 multicenter randomized 66 multicentre 66 Phase 2b trial 66 multicenter clinical 66 Phase 1a 66 Phase III clinical 65 Phase 1b trial 65 label dose escalation 65 double blinded placebo 65 Phase IIb 65 Phase III pivotal 65 Pivotal Trial 65 ATTRACT 65 pivotal Phase III 65 relapsed refractory multiple myeloma 65 nab paclitaxel 65 Pivotal Phase III 65 Phase Ia 64 BAY #-# 64 Phase III 64 Phase IIa 64 placebo controlled clinical 64 Phase IIb clinical 64 CR# vcMMAE 64 NSABP 63 relapsed multiple myeloma 63 axitinib 63 HER2 positive metastatic breast 63 confirmatory Phase III 63 tesmilifene 63 dose cohorts 63 Investigational Device Exemption IDE 63 prospective randomized controlled 62 Pirfenidone 62 prospective observational 62 Phase 62 Azedra 62 tanespimycin 62 PROPEL 62 Phase IIb trial 61 HGS ETR1 61 Initiates Phase 61 confirmatory Phase 3 61 dose escalation study 61 active comparator 61 Nexavar ® 61 humanized anti 61 ZYBRESTAT 61 DURATION 61 BLA submission 61 dose escalation 61 PF # [001] 61 Clinical Trial Results 61 randomized placebo controlled 61 Phase III Trial 61 randomized controlled clinical 61 TELCYTA 61 SCH # 60 investigational oral 60 blind randomized controlled 60 glatiramer acetate 60 CoFactor 60 multicenter 60 IIa clinical trial 60 Phase II 60 investigational compounds 60 Voreloxin 60 orally bioavailable 60 thymalfasin 60 metastatic renal cell carcinoma 60 KNS # 60 INCB# [002] 60 nitazoxanide 60 TG# [001] 60 HuMax CD# 60 blinded placebo controlled 60 TASQ